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1. Introduction 
1.1 Historical aspects 
The first case of syphilis occurred in Europe around the year 1493. Martin Alonzo Pinzon, 
commander of one of the three ships of Christopher Columbus, is considered as first 
documented victim of syphilis. The term "syphilis" was first described by the Italian 
physician and poet Giralomo Fracastoro in his epic noted poem titled “Syphilis sive morbus 
gallicus”. The first well-recorded European syphilis outbreak occured in 1494 during the 
siege of Naples by the French king Charles VIII (Hutto, 2001; Oriel, 1994; Bankl, 2002).  
A worldwide spread of syphilis could then be observed. In scientific reports around the 19th 
century specific forms of neurosyphilis were grouped under the multicausal term "Paralytic 
Dementia”. This term was defined as a syndrome, in which various forms of diseases such as 
syphilis, alcoholism, head injuries, hereditary diseases, and others were included. All of 
them presented demential and paralytical symptoms as common course (see graph 1). By 
the end of the 19th century approx. 45% of male patients hospitalized in psychiatric clinics 
in German speaking countries suffered from paralytic dementia. The number of patients 
suffering from neurosyphilis remains unclear. At the same time Emil Kraepelin reported 
that 34% of male patients suffered from a syphilis related paresis (Diefendorf, 1906). 
In 1905, Schaudinn and Hoffmann discovered Treponema pallidum in tissue of patients 
with syphilis. One year later, the first effective test for Syphilis, the “Wassermann Test”, was 
developed. In 1909, Nobel laureate Paul Ehrlich developed, together with his assistant 
Sahachiro Hata, Salvarsan, an arsenic compound, which is considered as the first effective 
treatment against syphilis before the penicillin era (Gensini et al, 2007). In 1913, Noguchi 
Hideyo demonstrated the presence of Treponema pallidum in the brain of progressive 
paralysis patients and was the first to establish a link between an infection with Treponema 
pallidum and the “Progressive paralysis” and “Tabes dorsalis” (Rulliere, 1992). The 
Austrian psychiatrist Julius Wagner Ritter von Jauregg tried inoculation of malaria 
parasites, which proved to be very successful in the case of dementia paralytica caused by 
neurosyphilis. It had been observed that patients who developed high fevers could be cured 
of syphilis as Treponema pallidum does not survive temperatures exceeding 41 ° C. In 1927, 
the discovery earned him the Nobel Prize in Physiology and Medicine (Nobel Lectures, 
1965).  
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Graph 1. From the multicausal term „Dementia paralytica“ to „Progressive paralysis“ as a 
form of neurosyphilis 
1.2 Epidemiological aspects 
The dicscovery of penicillin and its widespread manufacture after World War II led to a 
decrease in syphilis infection rates. Until the 1990s syphilis has become a rare disease. Due 
to the low incidence a “syphilis eradication program” was planned by the Centers for 
Disease Control and Prevention (CDC) (Klausner et al, 2005). At present, it is obvious that 
the disease has not been eradicated. Estimations of the World Health Organization speak of 
10-12 million new infections each year, primarily in developing countries of Africa and 
South America. Epidemiological data show a dramatic increase of infectious syphilis since 
the mid 1990s, mainly in the countries of the former Soviet Union, but also in Western 
European countries. A similar trend has been observed in the United States of America. 
According to recent epidemiological data rates of syphilis have been increasing in the 
United States and Europe, primarily among young adults and among men who have sex 
with men in urban areas or with individuals infected with HIV. It is important to mention, 
that the increase of syphilis prevalence is namely due to new infections (Lautenschlager, 
2006; Geusau, 2004; Wöhrl, 2007). 
1.3 Clinical aspects 
Due to the variety of its clinical presentations syphilis is called the chameleon of diseases, 
potentially affecting every organ of the body. Therefore, it is easy to overlook the symptoms 
at any stage. All symptoms of secondary stage will resolve with or without treatment and 
the patient enters the asymptomatic latent period in which an infection can be detected only 
by laboratory diagnosis. Two thirds of these patients remain asymptomatic. If left untreated, 
years to decades after primary infection, up to 30% of the affected individuals may develop 
tertiary syphilis. Tertiary syphilis can manifest as benign gummas, as cardiovascular disease 
(e.g. aneurysm of the ascending aorta), or as neurosyphilis (Workowski & Berman, 2006; 
Wöhrl 2007).  
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However, the central nervous system may be involved already in the secondary stage. In 
this context the authors would like to refer to psychiatric manifestations of syphilitic 
arteriitis with secondary thrombosis (Berlit, 2006; Wöhrl, 2007). 
Clinical manifestations of neurosyphilis can be divided into different subtypes (table 1).The 
asymptomatic form is characterized by the presence of a CNS infection as indicated by CSF 
abnormalities in the absence of psychiatric or other symptoms. Further, neurosyphilis is 
divided in a meningeal, a meningovascular, a parenchymatous, and a gummatous subform 
(Freedberg et al, 1999). This classification seems useful and is widely used (Flood et al, 1998, 
Friedrich et al, 2009). 
 
 
I. Asymptomatic 
II. Meningeal 
- acute meningitis 
-with hydrocephalus 
-with vertex involvement 
-with basiliar involvement 
- spinal pachymeningitis 
III. Meningovascular 
- cerebral 
- spinal 
-meningomyelitis 
-acute transverse meningitis 
IV. Parenchymatous 
- general paresis 
- tabes dorsalis 
- optic atrophy 
V. Gummatous 
-  cerebral compression symptoms 
-  spinal compression symptoms 
 
Table 1. Classification of neurosyphilis (Freedberg et al, 1999) 
2. Psychiatric manifestations of neurosyphilis 
Clinical manifestations as well as psychiatric symptoms of syphilis are diverse and have to 
be considered as non-specific. Table 2 gives an overview of psychiatric manifestations of 
neurosyphilis, classified according to the Tenth revision of the International Classification of 
Disease and Related Health Problems (= ICD-10) diagnoses. 
Only few and inconsistent data about the prevalence of psychiatric manifestations of 
neurosyphilis can be found. In a retrospective analysis Timmermans et al (2004) report that 
approximately 51% of 161 patients diagnosed with neurosyphilis presented 
neuropsychiatric symptoms. A Danish study carried out over 17 years by Danielsen et al 
(2004) reports of 92 patients suffering of neurosyphilis: 36% of these patients initially 
presented with neurological symptoms, 17% with psychiatric manifestations. 
Clinical manifestations of neurosyphilis are protean as stated above. A retrospective 
analysis of 117 patients by Flood et al (1998) shows a wide range of courses and symptoms 
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of neurosyphilis: 32% were asymptomatic, 33% presented personality changes, 28% of the 
patients had ataxia, 23% had a stroke, and 17% had ocular symptoms. 17 % of the patients 
reported bladder disturbance, whilst 10% had typical shooting pains due to tabes dorsalis. 
Headache, dizziness, or hearing loss was observed in 10% of the patients, 7% of the patients 
had cerebral seizures. Mitsonis et al (2008) examined medical records of 81 patients 
suffering from neurosyphilis. Between 1965-1984 approx. 27% of the individuals showed 
psychiatric manifestations, while between 1985-2005 almost 86% had psychiatric symptoms. 
The reason for this difference could not be explained by the authors. 
 
Hoche (1912) ICD-10: DD Literatur 
simple 
demential 
course 
F0: dementia Montejo et al 1995; Goeman et al 1996; Russouw et al 
1997; Antonowicz 1998; Fox et al. 2000; Hutto et al 2000; 
Fujimoto et al 2001; Polsky et al 2001; Morikawa et al 
2002; Xue et al 2004; Timmermans et al 2004; Blatz et al 
2005; Lee et al 2005; Lessig et al 2006; Mahmoudi et al. 
2006; Brinar et al 2006; Gabriel et al 2007; Van Eijsden et 
al 2008; Luo et al 2008; Lee et al 2009; Ates et al 2009; 
Mehrabian et al 2009; Yu et al 2010; Güler et al 2010 
 F0:others  Zifko et al 1995; Russouw et al 1997; Boerner 1997; 
Flood et al 1998; Denays et al 1999; Mancuso et al 2000; 
Sobhan et al 2004; Ilankovic et al 2004; Lair et al 2004; 
Blatz et al 2005; Estevez 2006; Foatelli et al 2006; 
Sanchez et al 2007; Mannekote et al 2008; Tibrewal et al 
2008 
 F1 Cnossen et al 1995;  Hutto et al 2000; Hutto 2001; Saik et 
al 2004; Blatz et al 2005; Yu et al 2009; Spiegel et al 2010 
paranoid course F2 Patkar et al 1997; Russouw et al 1997; Hutto et al 2000; 
Kohler et al. 2000; Kararizou et al 2006; Taycan et al 
2006; Turan et al 2007;  Friedrich et al. 2009 
depressive 
course 
F3 Zifko et al 1995; König et al 1996; Masmoudil et al 1996; 
Russouw et al 1997; Hutto et al 2000; Ide et al 2004; 
Blatz et al 2005; Mirsal et al 2007; Woo et al 2007; 
Cubała et al 2008 
euphoric- 
expansive 
course 
F31: mania Bschor et al. 1995; Dawson & Baldwin 1996; Palicio et al 
1996; Mimura et al 1997; Russouw et al 1997; Dunivin & 
Foust 1999; Kornischka 1999; Mendez 2000; Mahendran 
2001; Spiegel et al 2010 
 F4 Boyle et al 1995, Schreiber 1996; Aigner et al 1997; 
Hutto et al 2000 
 F6 Zifko et al 1995; Tso et al 2008 
(DD= differential diagnosis; F= ICD-10 Chapter V: Mental and behavioural disorders)  
Table 2. Publications with psychiatric differential diagnosis of neurosyphilis according to 
ICD-10 compared to the classification of Hoche (1912);  
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In an earlier survey carried out by Hooshmand and colleagues (1972), data of 241 
neurosyphilis patients were analysed for the period between 1965 and 1970.  The majority of 
the patients presented with rather mild complaint forms of primarily peripheric neuropathic 
symptoms, while psychiatric manifestations seemed to be rare: 5% presented depression, 3% 
manic states and 2% presented personality changes. 
Danielsen et al (2004) carried out another analysis of the various forms of neurosyphilis 
distinguishing between frequency and occurrence of psychiatric symptoms:  27% of patients 
were asymptomatic, while 10% were diagnosed with a meningovascular, 50 % with a 
parenchymatous, and 13% with a non-classifiable form of syphilis. Psychiatric 
manifestations could only be found in parenchymatous forms of neurosyphilis. 
In his work from 1912, Hoche divides the course of psychopathological forms of progressive 
paralysis into an euphoric-expansive, a depressed, a paranoid, and a simple dementia onset 
form. This nomenclature is also found in today´s psychiatric textbooks as a valid 
classification. In this context Bonhoeffer´s axiom of non-specific noxa concerning organic 
psychosyndromes has to be mentioned: different kinds of primary or secondary affections of 
the brain can result in an organic brain syndrome, which does not seem to be differentiable 
in psychopathological terms. On the other hand, different types of organic brain syndromes 
can be found despite identical underlying somatic disease (Bonhoeffer, 1917). Table 2 shows 
a wider diagnostic spectrum with further progressions for psychiatric manifestations of 
neurosyphilis. 
Analysing the psychopathological aspects with reference to the ICD-10 (see table 2) different 
kinds of manifestations of acute (e.g. amnestic passage syndrome), and chronic organic 
psychosyndromes (e.g. organic personality changes) can be observed. A great number of 
publications focus on demential syndromes (e.g. Yu et al, 2010; Ates et al, 2009). Goeman 
and colleagues (1996) for example report in their survey on the occurrence of dementia 
symptoms in a 15-year-old boy with congenital syphilis. Meteo-Ayuso´s (2000) 
recommendation for dementia symptoms accompanying syphilis is a symptomatic 
treatment with acetylcholinesterase inhibitors and / or memantines. Furthermore, various 
national Alzheimer societies recommend syphilis serologic testing as part of routine medical 
investigation of a demential syndrome (e.g. Schmidt et al, 2010). 
A few case reports on substance dependence in association with neurosyphilis are available. 
Hutto (2001, 2000) reports of a patient initially treated for cocaine dependency, depression, 
and psychotic symptoms. Initial syphilis screening detected the eventual presence of 
neurosyphilis. Similar cases can be found for alcohol dependence (e.g. Cnossen et al, 1995; 
Blatz et al, 2005; Hutto, 2000). These cases show in particular the eventual co-incidence of a 
syphilis infection and psychiatric disorders. 
Manifestations of syphilis with psychotic symptoms can vary from specific forms of 
hallucinations (e.g. Russouw et al, 1997) to various schizophrenia like symptoms (e.g. 
Kornischka, 1999; Friedrich et al, 2009). Some authors report of an improvement of psychotic 
symptoms after the initiation of causal penicillin therapy (e.g. Mannekote et al, 2008; 
Friedrich et al, 2009). However, it should be noted that the overall benefit of antibiotic 
therapy in advanced neuronal damage is limited. Only a few data is available on different 
antipsychotic treatment regimens for syphilitic psychotic state images: Turan er al (2007) 
carried out an evaluation of ziprasidone in comparison to olanzapine, Taykan et al (2006) 
the effect of quetiapine and risperidone. Furthermore, Rothenhäusler (2007) recommends 
the application of quetiapine and aripiprazole for the treatment of "syphilitic psychosis", in 
addition to antibiotic therapy. 
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Some publications report of mood disorders associated with neurosyphilis: depressive states 
(e.g. Frank et al, 1996) are described, as well as manic episodes (e.g. Mahendran et al, 2001). 
Rozwens and colleagues (2003) report that approx. 27% of patients with psychiatric 
manifestations of neurosyphilis presented depressive symptoms in association with 
psychomotoric retardation, melancholia, and suicidal thoughts. 
The reader should be aware that apart from manifestations classified by the ICD-10-F 
further psychiatric-related manifestations of neurosyphilis may occur, such as epileptic 
seizures (eg, Gürses et al, 2007; Sinha et al, 2008), autism (eg, Blatz et al, 2005), paresis (eg, 
Chen et al, 2005), pain symptoms (Mao et al, 2009), parkinsonism (Spitz et al, 2008), and 
Huntington's chorea (Ozben et al, 2009). 
3. Discussion and conclusion 
In past decades, neurosyphilis has been perceived as a rare, almost forgotten and “historic 
disease”. The rise of new infections with Treponema pallidum has confronted junior 
colleagues in the medical community with a variety of symptoms and manifestations that 
they have rarely seen in association with syphilis. Most of them have little knowledge of the 
complex appearance, the diagnosis, and the therapeutic options for this infectious disease 
(Aigner et al, 1997). The appropriate screening for syphilis in serum by Treponema antibody 
tests, such as the Treponema Pallidum Particle Agglutination Test (TPPA), is necessary to 
reveal a tertiary syphilis. These tests are, in particular for asymptomatic patients in the stage 
of late latency, the only reference to an infection with Treponema pallidum (Wöhrl, 2007). 
Depending on the activity of the illness indicated by high titers of nontreponemal tests, 
further evaluation for neurosyphilis by clinical and cerebrospinal fluid investigations is 
indicated. It is recommended that each patient with clinically evident psychiatric symptoms 
should have blood screening for syphilis – and in case of positive test results – a lumbar 
puncture. 
The cost-benefit analysis of routine syphilis screening has been questioned in the recent past 
and current studies. In 2007, Cheng and colleagues (2007) emphasizes in terms of syphilis 
screening and intervention in 500.000 pregnant women the importance and efficacy of these 
tests. Recent epidemiological data show that syphilis is not only a problem of the so-called 
developing countries. There has been a recent increase of infection rates in industrialized 
countries of the Western world as well. Therefore, routine blood screening for syphilis in the 
psychiatric field remains a vital part of the investigation of psychiatric inpatients. Due to 
diversity of clinical manifestations of neurosyphilis (table 2) it is impossible to carry out a 
diagnosis only on the basis of clinical symptoms. 
The Centers for Disease Control and Prevention (CDC) defines confirmed neurosyphilis as 
any syphilis stage and a reactive CSF-Venereal Disease Research Laboratory (VRDL). 
Further the CDC defines presumptive neurosyphilis as any syphilis stage, a nonreactive 
CSF-VDRL, an elevated CSF protein or white blood cell (WBC) count in the absence of other 
known causes of these abnormalities, and clinical symptoms or signs consistent with 
neurosyphilis without other known causes for these abnormalities (Centers for Disease 
Control and Prevention, 2010; Marra, 2009). Recommended therapy for neurosyphilis is the 
use of Aqueous crystalline penicillin G 18-24 million units per day, administered as 3-4 
million units IV every 4 hours or continuous infusion, for 10-14 days. Furthermore, 
benzathine penicillin, 2.4 million units IM once per week up to 3 weeks are recommended 
after completion of the treatment regimen. If CSF pleocytosis was present initially, a CSF 
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examination should be repeated every 6 months until a normal cell count can be found. In 
the presence of a penicillin allergy, the use of ceftriaxone 2g daily (IV or IM) is suggested for 
10-14 days as alternative treatment (Centers for Disease Control and Prevention, 2010). 
Further, the authors would like to point out that there are no consensus and guidelines on 
how to deal with psychiatric manifestations in association with neurosyphilis (Sanchez et al, 
2007). Therefore, an analysis of existing data and the initiation of prospective surveys are 
important for an effective and comprehensive treatment of affected patients in the future. 
Psychiatrists play an essential role in the detection of syphilis and its late manifestations. 
Some authors (Hutto, 2001; Mirsal et al, 2007) state that psychiatric patients may have a 
higher risk to acquire syphilis during their lifetime. Impulse control dysfunctions, a high-
risk sexual behavior, such as promiscuity or unprotected sex, or cognitive impairment and 
difficulties in seeking health care and assistance may be the cause for it. 
Finally, there has to be a discussion on possibilities of co-morbidities in neurosyphilis and 
resulting difficulties in diagnosis. It often seems to be difficult to distinguish between pre-
existing psychiatric disorders with secondary aggravation due to neurosyphilis and a 
secondary psychiatric disorder as a result of neurosyphilis. The situation gets even more 
complicated in the presence of a co-infection with HIV.  Immunodeficiency may lead to a 
more rapid progression of syphilis to the stage of neurosyphilis, eventually with 
manifestations even a short time after infection (de Almeida et al, 2010; Marra, 2009). 
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